Search alternatives:
significantly largest » significantly larger (Expand Search), significantly less (Expand Search), significantly affect (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
Showing 141 - 160 results of 1,460 for search '(( significantly largest decrease ) OR ( significantly ((teer decrease) OR (nn decrease)) ))*', query time: 0.46s Refine Results
  1. 141
    Trust levels before and after the COVID-19 pandemic (n = 10,000).

    Trust levels before and after the COVID-19 pandemic (n = 10,000). by Alain Abi-Rizk (8549358)

    Published 2025
    Save to List
    Saved in:
  2. 142
    Variation of the most appropriate p value significance threshold with different ratios of the standard deviations and sample sizes.

    Variation of the most appropriate p value significance threshold with different ratios of the standard deviations and sample sizes. by Farrokh Habibzadeh (12256529)

    Published 2025
    Save to List
    Saved in:
  3. 143
    DataSheet1_Capsaicin suppresses ciliary function, while inducing permeability in bronchial epithelial cell cultures of COPD patients.docx

    DataSheet1_Capsaicin suppresses ciliary function, while inducing permeability in bronchial epithelial cell cultures of COPD patients.docx by Halil Ibrahim Toy (10533263)

    Published 2022
    “…Formoterol significantly prevented decreases in CBF induced by capsaicin. …”
    Save to List
    Saved in:
  4. 144
    Perinatal outcomes from January 2017 to December 2019 (pre-policy period: January-December 2017; post-policy period: January 2018-December 2019).

    Perinatal outcomes from January 2017 to December 2019 (pre-policy period: January-December 2017; post-policy period: January 2018-December 2019). by Ingvild Hersoug Nedberg (11384048)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  5. 145
    Cesarean section rates from January 2017 to December 2019 (pre-policy period: January-December 2017; post-policy period: January 2018-December 2019).

    Cesarean section rates from January 2017 to December 2019 (pre-policy period: January-December 2017; post-policy period: January 2018-December 2019). by Ingvild Hersoug Nedberg (11384048)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  6. 146
    Demographic presentation of the study population in the pre- (January-December 2017) and post-policy (January 2018-December 2019) periods.

    Demographic presentation of the study population in the pre- (January-December 2017) and post-policy (January 2018-December 2019) periods. by Ingvild Hersoug Nedberg (11384048)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  7. 147
    Baseline rates, trends, and changes in NICU transfer rates and perinatal mortality rates for cesarean section and vaginal births in the pre- (January-December 2017) and post-policy (January 2018-December 2019) period, including cumulative effect 2 years after policy change.

    Baseline rates, trends, and changes in NICU transfer rates and perinatal mortality rates for cesarean section and vaginal births in the pre- (January-December 2017) and post-policy... by Ingvild Hersoug Nedberg (11384048)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  8. 148
    Baseline rates, trends, and changes in cesarean section rates in the pre- (January-December 2017) and post-policy (January 2018-December 2019) period, including cumulative effect 2 years after policy change.

    Baseline rates, trends, and changes in cesarean section rates in the pre- (January-December 2017) and post-policy (January 2018-December 2019) period, including cumulative effect 2... by Ingvild Hersoug Nedberg (11384048)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  9. 149
    Example of predicted effects of choice bundling on preference for larger, later rewards (LLRs) over smaller, sooner rewards (SSRs).

    Example of predicted effects of choice bundling on preference for larger, later rewards (LLRs) over smaller, sooner rewards (SSRs). by Jeffrey S. Stein (11689918)

    Published 2021
    Save to List
    Saved in:
  10. 150
    Matrix crosslinking decreases cell migration persistence.

    Matrix crosslinking decreases cell migration persistence. by Michael Pamonag (12295175)

    Published 2022
    Save to List
    Saved in:
  11. 151
    Expression and functionality of efflux transporters.

    Expression and functionality of efflux transporters. by Maj Schneider Thomsen (10297019)

    Published 2021
    Save to List
    Saved in:
  12. 152
    Expression of tight junction proteins.

    Expression of tight junction proteins. by Maj Schneider Thomsen (10297019)

    Published 2021
    Save to List
    Saved in:
  13. 153
    Kaplan-Meier analysis, patients with CVD and/or hypertension, baseline uncomplicated.

    Kaplan-Meier analysis, patients with CVD and/or hypertension, baseline uncomplicated. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  14. 154
    ACEi or ARB do not affect expression of ACE2 in lung epithelial cells.

    ACEi or ARB do not affect expression of ACE2 in lung epithelial cells. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  15. 155
    Baseline characteristics of patients in the uncomplicated phase of COVID-19.

    Baseline characteristics of patients in the uncomplicated phase of COVID-19. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  16. 156
    Biomarkers in uncomplicated patients with CVD/Hypertension.

    Biomarkers in uncomplicated patients with CVD/Hypertension. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  17. 157
    Mortality risk in patients with CVD and hypertension.

    Mortality risk in patients with CVD and hypertension. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  18. 158
    Mortality risk in patients with CVD and hypertension—Advanced disease.

    Mortality risk in patients with CVD and hypertension—Advanced disease. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  19. 159
    Biomarkers in all patients with CVD/Hypertension.

    Biomarkers in all patients with CVD/Hypertension. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  20. 160
    Baseline characteristics of patients included in the study.

    Baseline characteristics of patients included in the study. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:

Search Tools: